clinical trials

September 16, 2022

UW Medicine is part of a study aiming to enroll more than 500 adults with the virus, including pregnant and immune-deficient people.

May 24, 2021

Korea’s SK bioscience will receive up to $173.4 million to assess the efficacy of a new COVID-19 vaccine from Institute for Protein Design.

April 7, 2021

Phase 1 clinical trial at UW Medicine will determine safety, tolerability, and immune response to Gritstone experimental vaccine candidate

Subscribe to clinical trials